(Q24234341)

1

0 references

Marlene Delivuk

2

0 references

Andrea Chapman

3

0 references

Bradley N Gaynes

4

0 references

Angela Kaminski

Cochrane Database of Systematic Reviews

5

0 references

publication date

7 December 2011

0 references

published in

0 references

cites work

The Can-SAD study: a randomized controlled trial of the effectiveness of light therapy and fluoxetine in patients with winter seasonal affective disorder

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008591.PUB2

O sweet spot where art thou? Light treatment of Seasonal Affective Disorder and the circadian time of sleep

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008591.PUB2

Therapeutic mechanism in seasonal affective disorder: do fluoxetine and light operate through advancing circadian phase?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008591.PUB2

Treatment of seasonal affective disorder with duloxetine: an open-label study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008591.PUB2

Reboxetine in seasonal affective disorder: an open trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008591.PUB2

Therapeutic effects of escitalopram and reboxetine in seasonal affective disorder: a pooled analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008591.PUB2

Effects of fluoxetine versus bright light in the treatment of seasonal affective disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008591.PUB2

A placebo-controlled study of sertraline in the treatment of outpatients with seasonal affective disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008591.PUB2

Antidepressants versus placebo for depression in primary care

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008591.PUB2

Grading quality of evidence and strength of recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008591.PUB2

Selective serotonin reuptake inhibitors and risk of suicide: a systematic review of observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008591.PUB2

Interactions of the serotonin and circadian systems: nature and nurture in rhythms and blues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008591.PUB2

Fluoxetine versus other types of pharmacotherapy for depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008591.PUB2

Escitalopram versus other antidepressive agents for depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008591.PUB2

Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008591.PUB2

Sertraline versus other antidepressive agents for depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008591.PUB2

Evaluating non-randomised intervention studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008591.PUB2

Comparative benefits and harms of second-generation antidepressants: background paper for the American College of Physicians.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008591.PUB2

The general and comparative efficacy and safety of duloxetine in major depressive disorder: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008591.PUB2

The Efficacy of Light Therapy in the Treatment of Mood Disorders: A Review and Meta-Analysis of the Evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008591.PUB2

Controlling for drug dose in systematic review and meta-analysis: a case study of the effect of antidepressant dose

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008591.PUB2

Novel melatonin-based therapies: potential advances in the treatment of major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008591.PUB2

Estimated prevalence of the seasonal subtype of major depression in a Canadian community sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008591.PUB2

Active placebos versus antidepressants for depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008591.PUB2

Milnacipran versus other antidepressive agents for depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008591.PUB2

The MOS 36-ltem Short-Form Health Survey (SF-36)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008591.PUB2

A Structured Interview Guide for the Hamilton Depression Rating Scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008591.PUB2

Escitalopram in Seasonal Affective Disorder: Results of an Open Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008591.PUB2

Moclobemide and fluoxetine in treatment of seasonal affective disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008591.PUB2

Personality and seasonal affective disorder: results from the CAN-SAD study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008591.PUB2

7 January 2021

Treatment compliance in light therapy: Do patients do as they say they do?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008591.PUB2

7 January 2021

Quality of life as an outcome indicator in patients with seasonal affective disorder: results from the Can-SAD study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008591.PUB2

7 January 2021

Update on the biology of seasonal affective disorder.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008591.PUB2

7 January 2021

Monoaminergic function in the pathogenesis of seasonal affective disorder.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008591.PUB2

7 January 2021

Multicenter, placebo-controlled study of fluoxetine in seasonal affective disorder

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008591.PUB2

7 January 2021

The impact of latitude on the prevalence of seasonal depression

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008591.PUB2

7 January 2021

Comparative risk for harms of second-generation antidepressants : a systematic review and meta-analysis.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008591.PUB2

7 January 2021